TipRanks
Rici Healthcare Holdings Ltd. (HK:1526)
:1526
Hong Kong Market
1526
Rici Healthcare Holdings Ltd.
RESEARCH TOOLSreports
Want to see HK:1526 full AI Analyst Report?

Rici Healthcare Holdings Ltd. (1526) Ratios

1 Followers

Rici Healthcare Holdings Ltd. Ratios

HK:1526's free cash flow for Q2 2026 was ¥0.35. For the 2026 fiscal year, HK:1526's free cash flow was decreased by ¥ and operating cash flow was ¥0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.95 0.98 0.84 0.66 0.63
Quick Ratio
 0.93 0.96 0.81 0.65 0.60
Cash Ratio
 0.63 0.64 0.56 0.37 0.33
Solvency Ratio
 0.24 0.23 0.13 0.22 0.12
Operating Cash Flow Ratio
 0.42 0.40 0.40 0.38 0.33
Short-Term Operating Cash Flow Coverage
 2.05 1.83 1.46 1.28 1.15
Net Current Asset Value
¥ -1.38B¥ -1.41B¥ -1.82B¥ -2.09B¥ -2.31B
Leverage Ratios
Debt-to-Assets Ratio
 0.40 0.41 0.47 0.49 0.50
Debt-to-Equity Ratio
 1.13 1.22 1.71 2.01 2.41
Debt-to-Capital Ratio
 0.53 0.55 0.63 0.67 0.71
Long-Term Debt-to-Capital Ratio
 0.12 0.13 0.16 0.16 0.25
Financial Leverage Ratio
 2.80 2.96 3.61 4.12 4.79
Debt Service Coverage Ratio
 1.97 1.85 1.00 1.20 0.66
Interest Coverage Ratio
 6.56 6.64 4.74 5.17 3.51
Debt to Market Cap
 0.47 0.40 0.43 0.53 1.28
Interest Debt Per Share
 1.25 1.33 1.53 1.51 1.52
Net Debt to EBITDA
 0.81 0.78 1.48 1.36 2.76
Profitability Margins
Gross Profit Margin
42.91%43.19%39.93%41.75%39.04%
EBIT Margin
21.98%24.31%21.41%22.48%18.19%
EBITDA Margin
36.74%39.30%27.31%35.74%24.11%
Operating Profit Margin
21.40%23.79%20.77%21.95%18.19%
Pretax Profit Margin
19.22%20.29%16.55%18.23%13.78%
Net Profit Margin
10.64%10.99%10.17%12.16%12.24%
Continuous Operations Profit Margin
13.20%13.70%12.13%13.43%10.24%
Net Income Per EBT
55.34%54.13%61.44%66.68%88.88%
EBT Per EBIT
89.80%85.30%79.66%83.06%75.75%
Return on Assets (ROA)
6.32%6.29%6.12%7.84%6.37%
Return on Equity (ROE)
17.86%18.65%22.09%32.28%30.48%
Return on Capital Employed (ROCE)
19.97%21.58%21.18%26.57%17.90%
Return on Invested Capital (ROIC)
11.39%12.01%12.09%14.30%10.90%
Return on Tangible Assets
6.34%6.31%6.14%7.87%6.37%
Earnings Yield
24.30%19.20%15.92%22.15%39.82%
Efficiency Ratios
Receivables Turnover
 6.12 5.41 9.02 9.99 8.52
Payables Turnover
 11.03 10.21 10.82 10.61 8.48
Inventory Turnover
 59.32 54.01 35.27 46.61 25.84
Fixed Asset Turnover
 1.04 1.00 1.05 1.09 0.89
Asset Turnover
 0.59 0.57 0.60 0.65 0.52
Working Capital Turnover Ratio
 -42.87 -15.20 -5.57 -3.93 -3.43
Cash Conversion Cycle
 32.65 38.51 17.07 9.94 13.89
Days of Sales Outstanding
 59.59 67.49 40.45 36.52 42.83
Days of Inventory Outstanding
 6.15 6.76 10.35 7.83 14.13
Days of Payables Outstanding
 33.10 35.74 33.72 34.41 43.07
Operating Cycle
 65.75 74.25 50.79 44.35 56.96
Cash Flow Ratios
Operating Cash Flow Per Share
 0.44 0.45 0.50 0.52 0.44
Free Cash Flow Per Share
 0.34 0.35 0.37 0.31 0.25
CapEx Per Share
 0.10 0.10 0.13 0.21 0.19
Free Cash Flow to Operating Cash Flow
 0.77 0.78 0.74 0.59 0.56
Dividend Paid and CapEx Coverage Ratio
 4.27 4.56 2.81 1.60 2.28
Capital Expenditure Coverage Ratio
 4.27 4.56 3.83 2.44 2.28
Operating Cash Flow Coverage Ratio
 0.37 0.36 0.34 0.36 0.31
Operating Cash Flow to Sales Ratio
 0.25 0.26 0.27 0.28 0.30
Free Cash Flow Yield
44.42%35.10%31.30%29.65%54.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 4.07 5.29 6.28 4.52 2.51
Price-to-Sales (P/S) Ratio
 0.44 0.57 0.64 0.55 0.31
Price-to-Book (P/B) Ratio
 0.73 0.97 1.39 1.46 0.77
Price-to-Free Cash Flow (P/FCF) Ratio
 2.25 2.85 3.20 3.37 1.84
Price-to-Operating Cash Flow Ratio
 1.73 2.22 2.36 1.99 1.03
Price-to-Earnings Growth (PEG) Ratio
 0.22 0.00 -0.36 0.13 -0.11
Enterprise Value Multiple
 2.00 2.24 3.82 2.90 4.03
Enterprise Value
 2.05B 2.46B 3.05B 3.10B 2.31B
EV to EBITDA
 2.00 2.24 3.82 2.90 4.03
EV to Sales
 0.74 0.88 1.04 1.04 0.97
EV to Free Cash Flow
 3.79 4.38 5.22 6.36 5.83
EV to Operating Cash Flow
 2.90 3.42 3.86 3.75 3.27
Tangible Book Value Per Share
 1.06 1.07 0.85 0.69 0.57
Shareholders’ Equity Per Share
 1.05 1.04 0.85 0.71 0.60
Tax and Other Ratios
Effective Tax Rate
 0.31 0.32 0.27 0.26 0.26
Revenue Per Share
 1.75 1.76 1.84 1.88 1.49
Net Income Per Share
 0.19 0.19 0.19 0.23 0.18
Tax Burden
 0.55 0.54 0.61 0.67 0.89
Interest Burden
 0.87 0.83 0.77 0.81 0.76
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.26 0.19 0.19 0.07 0.09
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 >-0.01 <0.01
Income Quality
 1.21 1.27 1.63 2.27 2.43
Currency in CNY